INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Reply New Message

Prev Message Back To Forum Threaded View Next Message

agoracom administrator

Rank: Administrator [?]

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

posted on Oct 13, 2021 12:48PM

We just sat down with CEO Steve Saviuk.

We discuss:

Listing of blood thinner drug with 2 group purchasing organizations
Agreement Supports $30M Annual Revenue Target From Blood Thinner Product Alone
Represents 700 hospital and healthcare facilities across Canada

OUT TONIGHT

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply